Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: recAP

AM-Pharma – recombinant human Alkaline Phosphatase

Posted on by

AM-Pharma is a biopharma company developing a proprietary recombinant human Alkaline Phosphatase (recAP) against Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.

AM-Pharma – recombinant human Alkaline Phosphatase

AM-Pharma Continue reading →

Posted in Biotech Companies, Biotech Companies Netherlands | Tagged Acute Kidney Injury, AKI, alkaline phosphatase, AM-Pharma, AM-Pharma - recombinant human Alkaline Phosphatase, AMPharma, Andrea van Elsas, Ashok Dhanrajgir, Can Ince, David Donabedian, dephosphorylation, detoxifying agent, Edwin de Graaf, Erik van den Berg, extracellular ATP, Geert-Jan Mulder, Guido Magni, HPP, human Alkaline Phosphatase, Hypophosphatasia, Inflammatory Bowel Disease, Jacques Arend, Jean-Louis Vincent, Joannidis, Joël Jean-Mairet, Klaus Breiner, lipopolysaccharides, LPS, Moderate-to-Severe UC, Patrick Honoré, Peter Verwayen, Ravindra Mehta, recAP, recombinant Alkaline Phosphatase, recombinant human Alkaline Phosphatase, Rémi Droller, Russell Greig, Sander van Deventer, Steve Connor, Tim Knotnerus, Ulcerative Colitis, William Sandborn

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress